|
| Cleaved JAM-A - connecting cancer and vascular disease? |
|
https://doi.org/10.18632/oncotarget.26973
Cathy E. Richards, Emily J. Rutherford, Ann M. Hopkins
|
| 3831-3832 |
|
| Improving survival in salivary duct cancer with adjuvant androgen deprivation therapy |
|
https://doi.org/10.18632/oncotarget.27004
Wim van Boxtel, Carla van Herpen
|
| 3833-3834 |
|
| Immunomodulatory and immunotherapeutic implications of tobacco smoking in squamous cell carcinomas and normal airway epithelium |
|
https://doi.org/10.18632/oncotarget.26982
Jingming Wang, Maximilian Linxweiler, Wei Yang, Timothy A. Chan, Luc G.T. Morris
|
| 3835-3839 |
|
| Multidisciplinary palliation for unresectable recurrent rectal cancer: hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study |
|
https://doi.org/10.18632/oncotarget.26972
Stefano Guadagni, Giammaria Fiorentini, Andrea Mambrini, Francesco Masedu, Marco Valenti, Andrew Reay Mackay, Donatella Sarti, Enrico Ricevuto, Marco Clementi, Marco Catarci, Gianni Lazzarin, Gemma Bruera
|
| 3840-3851 |
|
| Downregulation of Friend Leukemia Integration 1 (FLI1) follows the stepwise progression to gastric adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.26974
Armando Del Portillo, Elena V. Komissarova, Aqiba Bokhari, Caitlin Hills, Anne Koehne de Gonzalez, Sarawut Kongkarnka, Helen E. Remotti, Jorge L. Sepulveda, Antonia R. Sepulveda
|
| 3852-3864 |
|
| Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma |
|
https://doi.org/10.18632/oncotarget.26988
Priyal O. Patel, Kathleen I. Pishas, Cenny Taslim, Julia Selich-Anderson, Emily R. Theisen, Stephen L. Lessnick
|
| 3865-3878 |
|
| Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor |
|
https://doi.org/10.18632/oncotarget.26989
Tomasz Kolenda, Piotr Rutkowski, Michał Michalak, Katarzyna Kozak, Kacper Guglas, Marcel Ryś, Łukasz Galus, Sebastian Woźniak, Iwona Ługowska, Aleksandra Gos, Anna Teresiak, Andrzej Mackiewicz, Katarzyna Lamperska, Jacek Mackiewicz
|
| 3879-3893 |
|
| Prioritization of metabolic genes as novel therapeutic targets in estrogen-receptor negative breast tumors using multi-omics data and text mining |
|
https://doi.org/10.18632/oncotarget.26995
Dinesh Kumar Barupal, Bei Gao, Jan Budczies, Brett S. Phinney, Bertrand Perroud, Carsten Denkert, Oliver Fiehn
|
| 3894-3909 |
|
| A priori prediction of breast tumour response to chemotherapy using quantitative ultrasound imaging and artificial neural networks |
|
https://doi.org/10.18632/oncotarget.26996
Hadi Tadayyon, Mehrdad Gangeh, Lakshmanan Sannachi, Maureen Trudeau, Kathleen Pritchard, Sonal Ghandi, Andrea Eisen, Nicole Look-Hong, Claire Holloway, Frances Wright, Eileen Rakovitch, Danny Vesprini, William Tyler Tran, Belinda Curpen, Gregory Czarnota
|
| 3910-3923 |
|
| Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall |
|
https://doi.org/10.18632/oncotarget.27001
Ann M. Moyer, Jia Yu, Jason P. Sinnwell, Travis J. Dockter, Vera J. Suman, Richard M. Weinshilboum, Judy C. Boughey, Matthew P. Goetz, Daniel W. Visscher, Liewei Wang
|
| 3924-3930 |
|
| Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma |
|
https://doi.org/10.18632/oncotarget.27002
Teresa Pollicino, Cristina Musolino, Carlo Saitta, Gianluca Tripodi, Marika Lanza, Giuseppina Raffa, Francesca Casuscelli di Tocco, Chiara Raggi, Maria Consiglia Bragazzi, Adalberto Barbera, Giuseppe Navarra, Pietro Invernizzi, Domenico Alvaro, Giovanni Raimondo
|
| 3931-3938 |
|
| Functional characterization of CNOT3 variants identified in familial adenomatous polyposis adenomas |
|
https://doi.org/10.18632/oncotarget.27003
Richard Glenn C. Delacruz, Imelda T. Sandoval, Kyle Chang, Braden N. Miller, Laura Reyes-Uribe, Ester Borras, Patrick M. Lynch, Melissa W. Taggart, Ernest T. Hawk, Eduardo Vilar, David A. Jones
|
| 3939-3951 |
|
| Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review |
|
https://doi.org/10.18632/oncotarget.26994
Muhamad N.A. Kamarudin, Ishwar Parhar
|
| 3952-3977 |
|
| Correction: Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals |
|
https://doi.org/10.18632/oncotarget.27023
Hongjun Xie, Chong Li, Qiang Dang, Luke S. Chang, Lei Li
|
| 3978-3978 |
